Study links tumor recurrence to growth factor commonly used in high-risk neuroblastoma treatment

Study links tumor recurrence to growth factor commonly used in high-risk neuroblastoma treatment

By Dana Benson A human growth factor that expands white blood cells in response to infection could be driving growth of neuroblastoma cancer stem cells that are thought responsible for disease relapse – a finding that could bring about changes in cancer treatment protocols, said researchers from Baylor College of Medicine in a new study … Continue reading